Patients experiencing pain along with their diabetic polyneuropathy are at an increased risk of vascular events and mortality.
Read More »Cardiovascular Risk While Using Insulin
The use of insulin to treat type 2 diabetes patients is growing, but does its risk for hypoglycemia impact cardiovascular health?
Read More »Metformin vs. Sulfonylureas: Heart Failure Hospitalization
A retrospective cohort analyzed the association of two commonly prescribed medications on heart failure outcomes in patients with reduced estimated glomerular filtration rate.
Read More »Intensive Glycemic and Blood Pressure Control Effects on QT Prolongation
Is QT prolongation the key to understanding the effect of intensive glucose control on diabetes mortality?
Read More »Benefits of GLP1 RA and SGLT-2 Inhibitors in Type 2 Patients
GLP1 RA and SGLT-2 were compared to evaluate coronary health disease reduction in patients with type 2 diabetes.
Read More »Speech Impediment a Risk for Type 2 Diabetes
A new study shows that teenage boys who stutter may have a higher likelihood of developing early-onset type 2 diabetes.
Read More »Metabolic Syndrome and Complication Risk in Type 1 Diabetes
Researchers sought to identify the prevalence of metabolic syndrome in patients with type 1 diabetes and its relationship to diabetic complication development.
Read More »Hyperglycemia Impact on Micro- and Macrovascular Disease
High glucose levels are known to potentiate microvascular complications, especially in people with diabetes, but does the same apply to people with normoglycemic levels?
Read More »Is Metformin the Best Choice for Type 2 Diabetes Patients?
Metformin has been associated with a higher incidence of peripheral neuropathy.
Read More »The Preferred Insulin for the Elderly
Long-acting insulins seem to be the best choice for elderly patients diagnosed with type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.